Claritas Pharmaceuticals Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Claritas Pharmaceuticals's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth | 6.0% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 30 Sep 2021 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Claritas Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 21 | 0 | 2 | 2 | -2 |
30 Jun 21 | 0 | 2 | 2 | -2 |
31 Mar 21 | 0 | -12 | 2 | -2 |
31 Dec 20 | 0 | 4 | 2 | -2 |
30 Sep 20 | 0 | -7 | 2 | 0 |
30 Jun 20 | 0 | -8 | 2 | 1 |
31 Mar 20 | 0 | -1 | 3 | 3 |
31 Dec 19 | 0 | -21 | 4 | 6 |
30 Sep 19 | 0 | -12 | 4 | 8 |
30 Jun 19 | 0 | -9 | 4 | 9 |
31 Mar 19 | 0 | 2 | 3 | 9 |
31 Dec 18 | 0 | 7 | 3 | 8 |
30 Sep 18 | 0 | -21 | 3 | 6 |
30 Jun 18 | 0 | -24 | 3 | 4 |
31 Mar 18 | 0 | -32 | 3 | 3 |
31 Dec 17 | 0 | -32 | 3 | 2 |
30 Sep 17 | 0 | -14 | 5 | 2 |
30 Jun 17 | 0 | -13 | 5 | 2 |
31 Mar 17 | 0 | -13 | 4 | 2 |
31 Dec 16 | 0 | -12 | 3 | 2 |
30 Sep 16 | 0 | -3 | 2 | 1 |
Quality Earnings: CLAZ.F has a high level of non-cash earnings.
Growing Profit Margin: Insufficient data to determine if CLAZ.F's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if CLAZ.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare CLAZ.F's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if CLAZ.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: CLAZ.F has a negative Return on Equity (0%), as it is currently unprofitable.